# Sangamo Therapeutics, Inc: Form 8-K, filed Oct 4, 2024

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: 8-K
- Filed: 2024-10-04
- Accepted by EDGAR: Oct 4, 2024, 16:03 ET
- Period: 2024-10-04
- Accession: 0001628280-24-042308
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/sgmo-20241004.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/sgmo-20241004.htm

Filed Oct 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-042308. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.